How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

7,013 results for

Glucose Tolerance Test 3 hour

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. A Practical Approach to the Management of Continuous Glucose Monitoring (CGM) / Real-Time Flash Glucose Scanning (FGS) in Type 1 Diabetes Mellitus in Children and Young People Under 18 Years

that patients with diabetes treated with insulin must comply with blood glucose testing no more than 2 hours before the start of the first journey and every 2 hours while driving. Drivers must also undertake regular blood glucose testing, at least twice daily, including on days when not driving. Blood glucose testing must be done on a meter with a memory function and three months of blood glucose readings whilst on insulin must be available. Continuous glucose monitoring (CGM) and flash glucose scanning (...) in reducing the risk of hyperglycaemia compared with any other pump systems” (MIB51) Recommended use of the Medtronic Minimed TM 640G (3) include: ? Children and young people with type 1 diabetes who experience problematic blood glucose levels undertaking capillary self-monitoring and multiple daily injections ? those who have difficulty identifying hypoglycaemia ? those with a history of severe hypoglycaemia ? those susceptible to nocturnal hypoglycaemia ? those with a fear of either daytime or night

2017 British Society for Paediatric Endocrinology and Diabetes

122. Five-hour Oral Glucose Tolerance Test in Obese Children Full Text available with Trip Pro

Five-hour Oral Glucose Tolerance Test in Obese Children 5129181 1972 02 25 2018 11 13 1468-2044 46 250 1971 Dec Archives of disease in childhood Arch. Dis. Child. Five-hour oral glucose tolerance test in obese children. 791-4 Court J M JM Dunlop M M Leonard I I Leonard R F RF eng Journal Article England Arch Dis Child 0372434 0003-9888 0 Blood Glucose 0 Fatty Acids, Nonesterified IY9XDZ35W2 Glucose PDC6A3C0OX Glycerol IM Administration, Oral Adolescent Age Factors Blood Glucose analysis Child (...) Child, Preschool Diabetes Mellitus genetics Fasting Fatty Acids, Nonesterified blood Female Glucose Glucose Tolerance Test Glycerol blood Humans Male Obesity diagnosis Time Factors 1971 12 1 1971 12 1 0 1 1971 12 1 0 0 ppublish 5129181 PMC1647907 J Clin Invest. 1965 Dec;44(12):2010-20 5851958 Ann N Y Acad Sci. 1965 Oct 8;131(1):662-72 5217000 Acta Med Scand. 1966 Feb;179(2):221-7 5908977 J Lab Clin Med. 1968 Mar;71(3):368-77 5645883 Clin Chim Acta. 1968 Jul;21(1):127-32 5658943 Diabetes. 1969 Nov;18

1971 Archives of Disease in Childhood

123. One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension. Full Text available with Trip Pro

One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension. The relationship between 1- and 2-h glucose levels following an oral glucose tolerance test (OGTT) and long-term mortality was evaluated.Over a 33-year period, 2138 individuals were followed for all-cause mortality. Fasting and post-OGTT glucose parameters categorized the cohort according to baseline glycaemic status. Four categories (...) were established according to 1- and 2-h glucose levels (in mmol/l): group A = 1 h ≤ 8.8 and 2 h < 7.8; group B = 1 h > 8.6 and 2 h < 7.8; group C = 1 h ≤ 8.6 and 2 h = 7.8-11.1 (impaired glucose tolerance); group D = 1 h > 8.6 and 2 h = 7.8-11.1 (impaired glucose tolerance). Individuals with diabetes at baseline were excluded from the cohort.By August 2013, 51% of the study cohort had died. The worst prognosis occurred in group D (73.8% mortality), followed by groups C (67.5%), B and A (57.9

2016 Diabetic Medicine

124. Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study. Full Text available with Trip Pro

Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study. In subjects with normal glucose tolerance (NGT) 1-hour postload plasma glucose (1-h oral glucose tolerance test [OGTT]) of >155 mg/dL predicts type 2 diabetes (T2DM) and is associated with subclinical atherosclerosis.The purpose of this study was to evaluate β-cell function, insulin resistance (...) of >155 mg/dL was found in 39% of subjects with NGT, 76% with impaired fasting glucose (IFG), 90% with impaired glucose tolerance (IGT), and 99% and 98% with IFG + IGT or newly diagnosed T2DM, respectively. Among subjects with NGT (n = 474), those with 1-hour OGTT glucose of >155 mg/dL were more insulin-resistant and had worse β-cell function than those with 1-hour OGTT glucose of ≤155 mg/dL. Moreover, glycosylated hemoglobin, blood pressure, low-density lipoprotein cholesterol, and triglycerides were

2013 Journal of Clinical Endocrinology and Metabolism

125. Two-hour post-load plasma glucose levels are associated with carotid intima-media thickness in subjects with normal glucose tolerance. (Abstract)

Two-hour post-load plasma glucose levels are associated with carotid intima-media thickness in subjects with normal glucose tolerance. Elevated post-load plasma glucose levels may increase the risk of cardiovascular disease, even when they are within the normoglycaemic range. We examined the association of carotid artery intima-media thickness, a marker of early atherosclerosis, with glycaemic variables, including post-load plasma glucose levels, in Japanese subjects with normal glucose (...) tolerance.The study participants were 663 Japanese subjects with normal glucose tolerance (565 men, mean age 47 ± 9 years) who underwent both a 75-g oral glucose tolerance test and carotid artery intima-media thickness measurement by B-mode ultrasonography during a health examination. Associations between maximal common carotid artery intima-media thickness and fasting plasma glucose, 1-h and 2-h plasma glucose during an oral glucose tolerance test, and HbA1c were examined.The carotid artery intima-media

2013 Diabetic Medicine

126. Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study. Full Text available with Trip Pro

empagliflozin 10 mg (n = 20), empagliflozin 25 mg (n = 19) or placebo (n = 21) once daily as monotherapy for 28 days. A meal tolerance test and continuous glucose monitoring (CGM) for 24 hours were performed at baseline and on days 1 and 28. The primary endpoint was change from baseline in area under the glucose concentration-time curve 3 hours after breakfast (AUC1-4h for PPG) at day 28.Adjusted mean (95%) differences versus placebo in changes from baseline in AUC1-4h for PPG at day 1 were -97.1 (-126.5 (...) Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study. This study evaluated the effect of empagliflozin on postprandial glucose (PPG) and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus (T2DM).Patients (N = 60; baseline mean [SD] HbA1c 7.91 [0.80]%; body mass index 24.3 [3.2] kg/m(2)) were randomized to receive

2015 Cardiovascular diabetology Controlled trial quality: predicted high

127. Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RT

and reassurance, and implement care plans, if appropriate, at the earliest opportunity. The aim of the study is to compare the clinical accuracy of HemoCue Glucose 201 RT with the laboratory standard method in the analysis of blood glucose concentration during oral glucose tolerance test. Condition or disease Intervention/treatment Cystic Fibrosis Other: Blood glucose results Detailed Description: All CF patients attending annual review who require an OGTT will have a venous and a capillary blood sample taken (...) of lung function and nutritional status, both of which increase mortality. The oral glucose tolerance test (OGTT) is the accepted method for detecting CFRD and the Cystic Fibrosis Trust guidelines recommend that patients with CF over the age of twelve years should be screened annually. The World Health Organisation has pointed out that due to the absence of a more specific biological marker to define diabetes, plasma glucose estimation remains the basis of diagnostic criteria. WHO recommends

2013 Clinical Trials

128. Continuous Glucose Monitoring and its Relationship to Hemoglobin A1c and Oral Glucose Tolerance Testing in Obese and Prediabetic Youth. Full Text available with Trip Pro

Continuous Glucose Monitoring and its Relationship to Hemoglobin A1c and Oral Glucose Tolerance Testing in Obese and Prediabetic Youth. The optimal screening test for diabetes and prediabetes in obese youth is controversial.We examined whether glycosylated hemoglobin (HbA1c) or the oral glucose tolerance test (OGTT) is a better predictor of free-living glycemia as measured by continuous glucose monitoring (CGM).This was a cross-sectional study of youth 10-18 years old, body mass index (BMI (...) greater than 140 and greater than 200 mg/dL. However, there were no overall differences in the strength comparisons between 2-hour glucose and HbA1c correlations to CGM outcomes.In obese youth, HbA1c and 2-hour glucose performed equally well at predicting free-living glycemia on CGM, suggesting that both are valid tests for dysglycemia screening.

2014 Journal of Clinical Endocrinology and Metabolism

129. Evaluation of 75 g glucose load in non-fasting state [Diabetes in Pregnancy Study group of India (DIPSI) criteria] as a diagnostic test for gestational diabetes mellitus Full Text available with Trip Pro

Evaluation of 75 g glucose load in non-fasting state [Diabetes in Pregnancy Study group of India (DIPSI) criteria] as a diagnostic test for gestational diabetes mellitus There is no consensus regarding optimal standard for diagnosis of gestational diabetes mellitus (GDM). In this study, use of 75 g glucose load in non-fasting state [Diabetes in Pregnancy Study Group of India (DIPSI) criteria] as a diagnostic test for GDM in pregnant women was compared with different oral glucose tolerance tests (...) (OGTTs).This prospective study included 936 pregnant women, who underwent plasma glucose evaluation two hours after the challenge of 75 g glucose load irrespective of the timing of last meal (DIPSI criteria for GDM). After three days, standard 75 g OGTT was done in all women irrespective of previous plasma glucose value. Accuracy of the first result was compared to OGTT using cut-offs as per the World Health Organization (WHO) and International Association of Diabetes and Pregnancy Study Groups

2017 The Indian journal of medical research

130. Basal rate tests (24 h fasts) performed in type-1 diabetic subjects with either absolute fasting or snacks containing negligible carbohydrate amounts result in similar glucose profiles - a randomized controlled prospective trial. (Abstract)

Basal rate tests (24 h fasts) performed in type-1 diabetic subjects with either absolute fasting or snacks containing negligible carbohydrate amounts result in similar glucose profiles - a randomized controlled prospective trial. Basal rate tests (24-hour fasting periods) may be necessary to optimize basal insulin replacement in type 1 diabetes. It was the aim of this study to prospectively compare the allowance of negligible carbohydrate snacks vs absolute fasting.A total of 20 patients (...) with type 1 diabetes (age, 48 ± 15 years (9 women, 11 men); BMI, 28.5 ± 4.5 kg/m2 ; HbA1c, 8.8% ± 2.0% (73.0 ± 21.9 mmol/mol); insulin dose, 0.69 ± 0.31 IU/kg body weight and per day) participated in 2 basal rate tests lasting 24 hours in random order with unchanged basal insulin replacement. On 1 occasion, negligible carbohydrate snacks (salads and vegetables, up to 5.1 g carbohydrate and 276.3 kJ per portion) were allowed; during the second test subjects were obliged to fast absolutely. Plasma glucose

2017 obesity & metabolism Controlled trial quality: uncertain

131. Impact of glucose excursion and mean glucose concentration in oral glucose-tolerance test on oxidative stress among Japanese Americans Full Text available with Trip Pro

Impact of glucose excursion and mean glucose concentration in oral glucose-tolerance test on oxidative stress among Japanese Americans To evaluate the impact of glucose excursion (GE) and mean glucose concentration (MGC) on oxidative stress among persons with or without diabetes.We examined 775 Japanese Americans who had normal glucose tolerance (NGT), impaired glucose tolerance, or diabetes according to the 75 g oral glucose-tolerance test, using fasting, 1-hour, and 2-hour glucose data. We (...) ). Association between GE and isoprostane was significant when adjustment was made for age, sex, smoking status, body mass index, C-reactive protein, glucose tolerance status, and homeostatic model assessment (P=0.029), but the association with MGC was not significant.Our results suggest the possibility that GE might result in oxidative stress, and the relationship is stronger than that for MGC.

2013 Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

132. Effect of age, hours since last food, time of day, and ketonuria on 1-hour glucose tolerance. Full Text available with Trip Pro

Effect of age, hours since last food, time of day, and ketonuria on 1-hour glucose tolerance. 5071315 1972 11 16 2018 11 13 0090-2918 87 7 1972 Aug-Sep Health services reports Health Serv Rep Effect of age, hours since last food, time of day, and ketonuria on 1-hour glucose tolerance. 649-57 Phillips N N Duffy T T eng Journal Article United States Health Serv Rep 0430452 0090-2918 0 Blood Glucose 0 Ketone Bodies AIM IM Adolescent Adult Age Factors Aged Blood Glucose analysis Eating Fasting (...) Female Glucose Tolerance Test standards Humans Ketone Bodies urine Middle Aged Statistics as Topic Time Factors 1972 8 1 1972 8 1 0 1 1972 8 1 0 0 ppublish 5071315 PMC1617005 Can Med Assoc J. 1969 Apr 19;100(15):692-8 5778955 J Clin Endocrinol Metab. 1970 May;30(5):602-8 4910526 Diabetologia. 1970 Aug;6(4):414-9 5452389 Public Health Rep. 1965 Mar;80:220-4 14265434 Diabetes. 1965 Jul;14:413-23 14318589 Arch Intern Med. 1963 Sep;112:338-43 14045277

1972 Health services reports

133. Insulin resistance of protein anabolism accompanies that of glucose metabolism in lean, glucose-tolerant offspring of persons with type 2 diabetes Full Text available with Trip Pro

Insulin resistance of protein anabolism accompanies that of glucose metabolism in lean, glucose-tolerant offspring of persons with type 2 diabetes To test whether protein anabolic resistance is an early defect in type 2 diabetes (T2D).Seven lean, normoglycemic T2D offspring (T2D-O) and eight matched participants without family history (controls; C) underwent a 3-hour hyperinsulinemic (40 mU/m2/min), euglycemic (5.5 mmol/L) and isoaminoacidemic clamp. Whole-body glucose and protein kinetics were (...) measured with d-[3-3H]glucose and l-[l-13C]leucine, respectively. Plasma amino acids were measured by liquid chromatography-tandem mass spectrometry.Fasting glycemia and glucose kinetic variables did not differ between groups. Clamp decreases in glucose rate of appearance were not different, but rate of disappearance increased 29% less in T2D-O, to a significantly lower rate. Fasting leucine was higher in T2D-O, but kinetics did not differ. Clamp increases in leucine oxidation and decreases

2016 BMJ open diabetes research & care

134. Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

] Glucose tolerance status in individuals with impaired glucose tolerance (IGT) will be measured after 24 months of:: i) treatment with the renal SGLT2 inhibitor, dapagliflozin; (ii) treatment with the DPP4 inhibitor, saxagliptin; (iii) treatment with the thiazolidinedione, pioglitazone; (iv) treatment with the biguanide, metformin. Glucose tolerance status will be evaluated by 2-hour plasma glucose concentration (mg/dl) during the OGTT. Beta cell function in individuals with isolated impaired fasting (...) Frame: 24 months after treatment phase begins ] Glucose tolerance status in individuals with isolated impaired fasting glucose (IFG) will be quantitated after 24 months of: (i) treatment with the renal SGLT2 inhibitor, dapagliflozin; (ii) treatment with the DPP4 inhibitor, saxagliptin; (iii) treatment with the thiazolidinedione, pioglitazone; (iv) treatment with the biguanide, metformin. Glucose tolerance status will be evaluated by measuring the and 2-hour plasma glucose concentration (mg/dl

2016 Clinical Trials

135. The Influence of Sampling Site When Assessing Glucose Tolerance or Insulin Sensitivity With Oral Glucose Ingestion

, 2016 Last Update Posted : October 25, 2016 Sponsor: University of Bath Information provided by (Responsible Party): Javier Gonzalez, University of Bath Study Details Study Description Go to Brief Summary: For decades, it has been known that post-meal blood glucose concentrations were associated with the risk of T2D, which was reflected in early diagnostic guidelines. The oral glucose tolerance test (OGTT) has been used since at least 1923 and has remained the most common test for assessing glucose (...) Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Rest Remain rested prior to the oral glucose tolerance test Behavioral: Rest Allowed to watch television or read for one hour prior to oral glucose tolerance test Other: Dorsal Hand Vein Cannulation (heated hand technique) Other: Venous Cannulation Experimental: Exercise Complete exercise prior to the oral glucose tolerance test Behavioral: Exercise One

2016 Clinical Trials

136. Study of Safety, Tolerability & Efficacy in Cystic Fibrosis Patients With Abnormal Glucose Tolerance

tolerance. Patients with abnormal glucose tolerance have elevated glucose level either at 1 hour or 2 hour during an Oral Glucose Tolerance Test (OGTT). The Main study will include 24 weeks of treatment with PBI-4050 or matching placebo. At the end of the treatment period, patients will have the option of participating in a 24-week Extension study. Condition or disease Intervention/treatment Phase Cystic Fibrosis Drug: PBI4050 Drug: Placebo Phase 2 Detailed Description: This is a Phase 2, multi-center (...) , double blind, placebo controlled study to evaluate the safety and tolerability of PBI-4050, and its effects on the pancreatic, pulmonary functions and on various biomarkers in Cystic Fibrosis patients with abnormal glucose tolerance. Patients with abnormal glucose tolerance have elevated glucose level either at 1 hour or 2 hour during an Oral Glucose Tolerance Test (OGTT). A total of 90 patients will be enrolled for study participation. A Data Safety Monitoring Board (DSMB) will continually review

2016 Clinical Trials

137. A1C Testing in the Diagnosis of Diabetes Mellitus

A1C Testing in the Diagnosis of Diabetes Mellitus A1C Testing in the Diagnosis of Diabetes Mellitus Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics A1C Testing in the Diagnosis of Diabetes Mellitus View/ Open Date 2006-07 Format Metadata Abstract A1C testing is highly specific compared with a two-hour oral glucose (...) tolerance test (OGTT) or a fasting plasma glucose test. However, because A1C testing is not sensitive enough to rule out diabetes if levels are normal, the test should not be used for diagnosing diabetes. (Strength of recommendation: C). URI Part of Citation American Family Physician, 74(1) 2006. Rights OpenAccess. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. Collections hosted by hosted by

2019 Clinical Inquiries

138. A1C Testing in the Diagnosis of Diabetes Mellitus

A1C Testing in the Diagnosis of Diabetes Mellitus A1C Testing in the Diagnosis of Diabetes Mellitus Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics A1C Testing in the Diagnosis of Diabetes Mellitus View/ Open Date 2006-07 Format Metadata Abstract A1C testing is highly specific compared with a two-hour oral glucose (...) tolerance test (OGTT) or a fasting plasma glucose test. However, because A1C testing is not sensitive enough to rule out diabetes if levels are normal, the test should not be used for diagnosing diabetes. (Strength of recommendation: C). URI Part of Citation American Family Physician, 74(1) 2006. Rights OpenAccess. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. Collections hosted by hosted by

2019 Clinical Inquiries

139. A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test

A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer (...) to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test (DXM2) The safety and scientific validity of this study

2013 Clinical Trials

140. Sustained Decrease of Early-Phase Insulin Secretion in Japanese Women with Gestational Diabetes Mellitus Who Developed Impaired Glucose Tolerance and Impaired Fasting Glucose Postpartum Full Text available with Trip Pro

Sustained Decrease of Early-Phase Insulin Secretion in Japanese Women with Gestational Diabetes Mellitus Who Developed Impaired Glucose Tolerance and Impaired Fasting Glucose Postpartum The aim of this study was to compare glucose intolerance in the antenatal and the postpartum periods using a 75-g oral glucose tolerance test (OGTT) in the Japanese women with gestational diabetes mellitus (GDM) using a retrospective design.Data were obtained from 85 Japanese women with GDM who delivered from (...) April 2011 through April 2015 and who underwent an OGTT 6-14 weeks postpartum. The women were divided into two groups based on the results of the postpartum OGTT: one group with normal glucose tolerance (NGT) and the other with impaired glucose tolerance (IGT) as well as impaired fasting glucose (IFG). We analyzed the associations between postpartum IGT-IFG and various factors.Antenatally, a significant difference was observed between the groups only in the 1-hour plasma glucose level of the 75-g

2015 Japanese clinical medicine

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>